Will file defamation suit against SAD's Majithia over drug scam allegation: Pb health minister

Image
Press Trust of India Chandigarh
Last Updated : Feb 29 2020 | 7:44 PM IST

Punjab Health Minister Balbir Singh Sidhu on Saturday said he will file a defamation suit against Akali leader Bikram Singh Majithia for allegedly levelling false allegations against him in connection with the diversion of buprenorphine tablets from private de-addiction centres (PDAC).

Speaking in the Punjab Assembly on Wednesday, Majithia had sought Sidhu's dismissal from the cabinet, alleging that five crore tablets of buprenorphine, a scheduled drug, worth Rs 200 crore had gone missing from the PDCAs.

Describing Majithia's allegations as "baseless and fallacious", Sidhu said he will file a defamation suit against the Shiromani Akali Dal (SAD) leader.

The previous SAD-BJP government "totally failed" to break the supply line of drugs and now the Akalis are trying to divert people's attention by politicising the issue, the health minister said.

Sidhu said the PDACs are authorised to directly purchase medicines from pharmaceutical companies and the health department has no role in the process.

The difference in online and offline records of medicines was noticed by the health department itself. After that, to ensure 100 per cent data entry online, show cause notices have been issued to the PDACs, he added.

Sidhu said he has directed Principal Secretary Anurag Aggarwal to conduct a thorough audit of all the PDACs.

He said he has also asked Aggarwal to ensure that treatment of patients is not affected during the audit.

He added that he is personally monitoring the issue and legal action will be taken after an analysis of the online and offline records of the PDACs.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 29 2020 | 7:44 PM IST

Next Story